NO20085214L - Nye pyridinanaloger - Google Patents
Nye pyridinanalogerInfo
- Publication number
- NO20085214L NO20085214L NO20085214A NO20085214A NO20085214L NO 20085214 L NO20085214 L NO 20085214L NO 20085214 A NO20085214 A NO 20085214A NO 20085214 A NO20085214 A NO 20085214A NO 20085214 L NO20085214 L NO 20085214L
- Authority
- NO
- Norway
- Prior art keywords
- pyridine analogs
- new pyridine
- formula
- analogs
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Formel ( I ) Foreliggende oppfinnelse angår visse nye pyridinanaloger med formel ( I ) til prosesser for fremstilling av slike forbindelser, til deres anvendelse som P2Y12 inhibitorer og som anti-trombotiske midler etc, anvendelse av dem som medikamenter i kardiovaskulære sykdommer og som farmasøytiske preparater inneholdende dem.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0601464 | 2006-07-04 | ||
PCT/SE2007/000643 WO2008004943A1 (en) | 2006-07-04 | 2007-07-02 | New pyridine analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085214L true NO20085214L (no) | 2009-01-14 |
Family
ID=38894822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085214A NO20085214L (no) | 2006-07-04 | 2008-12-15 | Nye pyridinanaloger |
Country Status (13)
Country | Link |
---|---|
US (2) | US20080045494A1 (no) |
EP (1) | EP2044024A4 (no) |
JP (1) | JP2009542643A (no) |
KR (1) | KR20090020712A (no) |
CN (1) | CN101511792A (no) |
AU (1) | AU2007270083A1 (no) |
BR (1) | BRPI0713400A2 (no) |
CA (1) | CA2656597A1 (no) |
IL (1) | IL195981A0 (no) |
MX (1) | MX2008016562A (no) |
NO (1) | NO20085214L (no) |
WO (1) | WO2008004943A1 (no) |
ZA (1) | ZA200810644B (no) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007008237A (es) * | 2005-01-06 | 2007-08-17 | Astrazeneca Ab | Compuestos de piridina novedosos. |
WO2007008140A1 (en) * | 2005-07-13 | 2007-01-18 | Astrazeneca Ab | New pyridine analogues |
TW200815426A (en) * | 2006-06-28 | 2008-04-01 | Astrazeneca Ab | New pyridine analogues II 333 |
TW200811133A (en) * | 2006-07-04 | 2008-03-01 | Astrazeneca Ab | New pyridine analogues III 334 |
MX2008016557A (es) * | 2006-07-04 | 2009-02-06 | Astrazeneca Ab | Analogos de piridina nuevos. |
BRPI0713401A2 (pt) * | 2006-07-04 | 2012-04-17 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação plaquetária |
PE20081633A1 (es) * | 2007-01-12 | 2009-01-18 | Astrazeneca Ab | Derivados de piridina como antagonistas del receptor p2y12 |
CL2008000093A1 (es) * | 2007-01-12 | 2008-08-22 | Astrazeneca Ab | Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria. |
AR064864A1 (es) * | 2007-01-12 | 2009-04-29 | Astrazeneca Ab | Compuestos analogos de piridina vii 543 y composicion farmaceutica |
PE20081892A1 (es) * | 2007-07-13 | 2009-02-21 | Astrazeneca Ab | Nuevos analogos de amino-piridina como agentes antitromboticos |
WO2012174013A2 (en) * | 2011-06-14 | 2012-12-20 | Cardeus Pharmaceuticals, Inc. | Treatment of cardiovascular disease, stroke, and inflammatory conditions |
US9539246B2 (en) | 2011-08-30 | 2017-01-10 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
EP1257550B1 (en) * | 2000-02-04 | 2005-11-16 | Portola Pharmaceuticals, Inc. | Platelet adp receptor inhibitors |
US7018985B1 (en) * | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
FR2820057A1 (fr) * | 2001-01-30 | 2002-08-02 | Ct De Transfert De Technologie | Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane |
US7504497B2 (en) * | 2003-10-21 | 2009-03-17 | Inspire Pharmaceuticals, Inc. | Orally bioavailable compounds and methods for inhibiting platelet aggregation |
US7335648B2 (en) * | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
US7749981B2 (en) * | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
EA200700117A1 (ru) * | 2004-06-24 | 2007-06-29 | Инсайт Корпорейшн | N-замещенные пиперидины и их применение в качестве фармацевтических препаратов |
US20080090863A1 (en) * | 2004-09-30 | 2008-04-17 | Taisho Pharmaceutical Co., Ltd. | Pyridine Derivatives and Their Use as Medicaments for Treating Diseases Related to Mch Receptor |
MX2008016557A (es) * | 2006-07-04 | 2009-02-06 | Astrazeneca Ab | Analogos de piridina nuevos. |
BRPI0713401A2 (pt) * | 2006-07-04 | 2012-04-17 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação plaquetária |
-
2007
- 2007-07-02 CN CNA2007800324831A patent/CN101511792A/zh active Pending
- 2007-07-02 KR KR1020097002220A patent/KR20090020712A/ko not_active Application Discontinuation
- 2007-07-02 JP JP2009518050A patent/JP2009542643A/ja active Pending
- 2007-07-02 US US11/772,261 patent/US20080045494A1/en not_active Abandoned
- 2007-07-02 BR BRPI0713400-2A patent/BRPI0713400A2/pt not_active IP Right Cessation
- 2007-07-02 AU AU2007270083A patent/AU2007270083A1/en not_active Abandoned
- 2007-07-02 WO PCT/SE2007/000643 patent/WO2008004943A1/en active Application Filing
- 2007-07-02 EP EP07748302A patent/EP2044024A4/en not_active Withdrawn
- 2007-07-02 US US12/307,281 patent/US20090286834A1/en not_active Abandoned
- 2007-07-02 CA CA002656597A patent/CA2656597A1/en not_active Abandoned
- 2007-07-02 MX MX2008016562A patent/MX2008016562A/es not_active Application Discontinuation
-
2008
- 2008-12-15 NO NO20085214A patent/NO20085214L/no not_active Application Discontinuation
- 2008-12-16 IL IL195981A patent/IL195981A0/en unknown
- 2008-12-17 ZA ZA200810644A patent/ZA200810644B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007270083A1 (en) | 2008-01-10 |
EP2044024A4 (en) | 2011-06-29 |
KR20090020712A (ko) | 2009-02-26 |
US20080045494A1 (en) | 2008-02-21 |
CN101511792A (zh) | 2009-08-19 |
MX2008016562A (es) | 2009-02-06 |
BRPI0713400A2 (pt) | 2012-04-17 |
ZA200810644B (en) | 2010-01-27 |
EP2044024A1 (en) | 2009-04-08 |
JP2009542643A (ja) | 2009-12-03 |
IL195981A0 (en) | 2009-09-01 |
CA2656597A1 (en) | 2008-01-10 |
WO2008004943A1 (en) | 2008-01-10 |
US20090286834A1 (en) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20085218L (no) | Nye pyridinanaloger | |
NO20085214L (no) | Nye pyridinanaloger | |
NO20085212L (no) | Nye pyridinanaloger | |
NO20085213L (no) | Nye pyridinanaloger | |
NO20076682L (no) | Nye pyridinanaloger | |
NO20073101L (no) | Nye pyridinforbindelser | |
NO20071504L (no) | Pyrimidinderivanter. | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20090783L (no) | Pyrimidonforbindelser som inhibitorer av GSK-3 | |
NO20090835L (no) | Nye HIV-reverstranskriptaseinhibitorer | |
NO20084202L (no) | 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer | |
NO20074592L (no) | Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
NO20074634L (no) | Substituerte heterocykler og deres anvendelse som CHK1-, PDK1- og PAK-inhibitorer | |
NO20063449L (no) | Substituerte heterocykler og deres anvendelse | |
NO20082124L (no) | Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom | |
WO2008144346A3 (en) | Crystal structures of sglt2 inhibitors and processes for their preparation | |
NO20084712L (no) | Nye farmasoytiske forbindelser | |
MY148634A (en) | Pyridazinone derivatives | |
NZ577916A (en) | Cyclopamine analogs | |
NO20090295L (no) | Substituerte heteroarylderivater | |
NO20081893L (no) | 4-(3-aminopyrazol)pyrimidinderivater til anvendelse som tyrosin-kinaseinhibitorer i behandling av kreft | |
NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
NO20074258L (no) | Pyridin-2-karboksamidderivater som MGLUR5 antagonister | |
NO20083905L (no) | Nye pyron-indol derivater og fremgangsmate for deres fremstilling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |